New obesity drug from Lilly delivers major weight loss
6 sources covered this
compare →
Coverage diverges in the emphasis placed on the drug's effectiveness and implications. TODAY.com highlights the "stunning" results and compares retatrutide favorably to existing GLP-1 medications, while the Washington Examiner focuses on…
·
0 reactions
·
0 comments
·
17 views
Original article
The Hill
Anonymous · no account needed